Allurion Technologies ALURD
ALURD
$3.28 -0.11 (-3.24%)
At close: Aug 18, 2026 · 4:00 PM EDT

Allurion Technologies (ALURD) Debt Ratio (2022 - 2024)

Allurion Technologies' (ALURD) quarterly Debt Ratio came in at 0.65 in Q1 2024, up 20.52% on a QoQ basis from 0.54 in Q4 2023.

Allurion Technologies (ALURD) Debt Ratio (2022 - 2024) Analysis & Trends

Allurion Technologies (ALURD) has 3 years of Debt Ratio data on file, last reported at 0.65 in Q1 2024.

  • Quarterly Debt Ratio changed N/A year-over-year to 0.65 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.65 (changed N/A YoY) and the FY2023 annual result came in at 0.54, down 48.12% from the prior year.
  • Debt Ratio advanced to 0.65 in Q1 2024, from 0.54 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.04 in Q4 2022 to a low of 0.48 in Q3 2023.
  • A 3-year average of 0.75 and a median of 0.65 in 2024 frame the typical range for Debt Ratio.
  • The widest YoY moves for Debt Ratio: up 48.12% in 2023, down 48.12% in 2023.
  • Tracing ALURD's Debt Ratio over 3 years: stood at 1.04 in 2022, then plunged by 48.12% to 0.54 in 2023, then advanced by 20.52% to 0.65 in 2024.
  • The last three Debt Ratio figures came in at 0.65 (Q1 2024), 0.54 (Q4 2023), and 0.48 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 0.30
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 0.31
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 0.30
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 0.28
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 0.04
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 0.27
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 0.28
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 0.18
10 Allurion Technologies 49.18 Mn 44.13 Mn 1.23 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2024 0.65
Dec 31, 2023 0.54
Sep 30, 2023 0.48
Jun 30, 2023 1.03
Dec 31, 2022 1.04